toggle navigation
HOME
ABOUT
Overview
History
Our Leadership
Our Advisors
Our Values
TECHNOLOGY
ATRIVIEW® CNS Drug Screening Platform
SHINE MOUSE® and NuvoMab™ Platform
Publications
PIPELINE
NEWS
News Release
Company Notice
CONTACT
LANGUAGE
KOREAN
ENGLISH
toggle navigation
HOME
ABOUT
Overview
History
Our Leadership
Our Advisors
Our Values
TECHNOLOGY
ATRIVIEW® CNS Drug Screening Platform
SHINE MOUSE® and NuvoMab™ Platform
Publications
PIPELINE
NEWS
News Release
Company Notice
CONTACT
LANGUAGE
KOREAN
ENGLISH
EN
|
KR
News
Title
GENUV, Receives Approval for ALS Phase 1·2a Clinical Studies on New Drug "SNR1611"
2019-09-19
Link :
http://m.docdocdoc.co.kr/news/articleView.html?idxno=1072351
Prev
GENUV, Receives Approval for ALS Phase 1·2a Clinical Studies on New Drug Candidate
Next
GENUV, Receives Approval for ALS Phase 1·2a Clinical Studies
list
